This multibagger stock hits upper circuit after FII picks stakeShares of Sampre Nutrients have zoomed as much as 565 per cent in the last one year, whereas the counter is up by 240 per cent on a year-to...
New committee to examine safety, rationality of over 300 drugs banned since 2016The committee will be headed by Dr Nilima Kshirsagar, chair of clinical pharmacology at the Indian Council of Medical Research, Mumbai, acc...
- Buy Procter & Gamble Hygiene & Healthcare Ltd. target Rs 8965: Equirus Securities
Buy Procter & Gamble Hygiene & Healthcare Ltd. at a price target of Rs 8965.
- NFL-National Football League roundup
FOOTBALL-NFL/ROUNDUP:NFL-National Football League roundup
- NFL-Falcons eye first Super Bowl title to crown Ryan's big season
NFL-SUPERBOWL/FALCONS:NFL-Falcons eye first Super Bowl title to crown Ryan's big season
These three MNC blue chips are cheap nowThe feminine hygiene business has been growing in double digits for 13 years, while Vicks has been consistently increasing its market share...
Procter & Gamble to rise in sanitary segment, while facing competition in healthcareIn the healthcare segment, Vicks is the leader however, there are several other players in this category which will restrict its growth to ...
Lobby groups of pharmaceutical companies considering petition against drug banLobby groups of pharmaceutical companies are leaving no stone unturned to get the health ministry’s ban on 344 fixed-dose combination (FDC)...
We’ve been fair in assessing banned drugs, says Chandrakant KokateKokate told ET that only those mentioned in the list were found to be irrational, while most others were spared regulatory action.
Procter and Gamble to resume manufacturing, sale of Vicks Action 500 ExtraGovernment has banned medicines including Vicks Action 500 Extra as part of its decision to stop the manufacture and sale of fixed dose com...
Delhi High Court stays ban on sale of Procter and Gamble's Vicks Action 500 till March 21Healthcare major Procter and Gamble today got interim relief from the Delhi High Court which stayed till March 21 government's decision ban...
P&G stops selling Vicks Action 500 Extra in India after banP&G said all its products, including Vicks Action 500 Extra, were backed by research to support their quality, safety and efficacy.
Delisting buzz fuels Gillette stock surgeThe two companies, P&G and Gillette, have a long history of working in India under different names and different partners.
It was a mistake to take HUL head on when we first entered India: AG Lafley, CEO, P&GOur view was that we could take a decade to improve our position in India. The other big strategy trap is the failure to make choices, says...
Teva Pharma, P&G sets up OTC plant in GujaratIsrael-based Teva Pharmaceuticals, an $18 billion generic drug maker will set up OTC medicine facility in Gujarat in collaboration with Pro...
- Procter & Gamble Q3 FY'10 profit up 26 pc at Rs 44 crore
Procter & Gamble Hygiene and Health Care (PGHH), a subsidiary of FMCG major P&G, on Friday said its net profit has jumped by 26 per cent to...
- P&G to launch new health care products from parent co's stable
Proctor & Gamble Hygiene and Health Care Ltd plans to launch personal health care and feminine care products developed by its parent compan...